These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


225 related items for PubMed ID: 6684226

  • 1. Myasthenia gravis: long-term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease severity.
    Besinger UA, Toyka KV, Hömberg M, Heininger K, Hohlfeld R, Fateh-Moghadam A.
    Neurology; 1983 Oct; 33(10):1316-21. PubMed ID: 6684226
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Myasthenia gravis: antibodies to acetylcholine receptor with human and rat antigens.
    Oda K, Goto I, Kuroiwa Y, Onoue K, Ito Y.
    Neurology; 1980 May; 30(5):543-6. PubMed ID: 7189261
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Enzyme-linked immunosorbent assay for antibody against the nicotinic acetylcholine receptor in human myasthenia gravis.
    Kawanami S, Tsuji R, Oda K.
    Ann Neurol; 1984 Feb; 15(2):195-200. PubMed ID: 6367620
    [Abstract] [Full Text] [Related]

  • 6. [Acetylcholine receptor antibodies in the diagnosis of myasthenia gravis. Study of 406 confirmed cases].
    Toyka KV, Heininger K.
    Dtsch Med Wochenschr; 1986 Sep 19; 111(38):1435-9. PubMed ID: 3757800
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Heterogeneity of antibodies blocking the binding of bungarotoxin to the acetylcholine receptor in myasthenia].
    Vernet-der-Garabédian B, Morel E, Bach JF.
    C R Acad Sci III; 1984 Sep 19; 298(16):449-56. PubMed ID: 6428718
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Are spontaneous anti-idiotypic antibodies against anti-acetylcholine receptor antibodies present in myasthenia gravis?
    Vincent AC.
    J Autoimmun; 1988 Apr 19; 1(2):131-42. PubMed ID: 3252806
    [Abstract] [Full Text] [Related]

  • 14. Binding and blocking antibodies to the human acetylcholine receptor: are they selected in various myasthenia gravis forms?
    Morel E, Vernet-der Garabedian B, Eymard B, Raimond F, Bustarret FA, Bach JF.
    Immunol Res; 1988 Apr 19; 7(3):212-7. PubMed ID: 3193008
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Acetylcholine receptor antibody characteristics in myasthenia gravis. Fractionation of alpha-bungarotoxin binding site antibodies and their relationship to IgG subclass.
    Whiting PJ, Vincent A, Newsom-Davis J.
    J Neuroimmunol; 1983 Aug 19; 5(1):1-9. PubMed ID: 6874919
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.